Exhibit 10.66
SHARE EXCHANGE AGREEMENT
This Share Exchange Agreement (this "Agreement") is made and entered
into as of the 31st day of August, 1999, by and between American Physicians
Service Group, Inc., a Texas corporation ("APS") and Jonathan B. Buten, M.D.
(the "Shareholder").
R E C I T A L S:
- - - - - - - -
WHEREAS, pursuant to that certain Agreement and Plan of Reorganization
(the "Merger Agreement") dated February 19, 1998, entered into by Shareholder
and Syntera HealthCare Corporation, a Texas corporation ("Syntera"), and the
other contracts and agreements to which Shareholder is a party as contemplated
in the Merger Agreement (the Merger Agreement and all such other contracts and
agreements are hereinafter referred to collectively as the "Acquisition
Documents"), Shareholder acquired 68,250 shares (the "Syntera Shares") of the
$0.001 par value per share common stock of Syntera; and
WHEREAS, in connection with the execution of the Merger Agreement, APS
and Shareholder entered into that certain Share Exchange Agreement dated May 18,
1998 (the "Original Agreement"); and
WHEREAS, APS and Shareholder have agreed to terminate the Original
Agreement upon the execution of this Agreement; and
WHEREAS, at the time of execution of this Agreement, Syntera and
Shareholder (in his capacity as a shareholder of Syntera) are contemplating a
proposed merger (the "Merger") between Syntera and a subsidiary of FemPartners,
Inc., a Delaware corporation ("FemPartners"), pursuant to which Syntera may or
may not be the surviving corporation; and
WHEREAS, notwithstanding the Merger and any effect it might have on
Shareholder's rights under the Original Agreement, APS has agreed, on the terms
and subject to the conditions hereof, to exchange cash, certain shares of its
$0.10 par value per share common stock ("APS Common"), shares of common stock,
par value $0.01, of Prime Medical Services, Inc., a Delaware corporation (the
"Prime Stock"), or a combination thereof, as determined by APS, for the Subject
Shares (as hereinafter defined).
NOW, THEREFORE, in consideration of the foregoing and other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows:
1. TERMINATION OF SHARE EXCHANGE AGREEMENT. Contemporaneous with
and contingent only upon the execution of this Agreement, the Original
Agreement is hereby terminated and revoked, and all rights and privileges
of the parties thereto are nullified.
2. EFFECT OF MERGER. In the event the Merger occurs on or before
December 31, 1999, the shares of FemPartners received by Shareholder in the
Merger, in return for the Syntera shares (the "FemPartners Shares"), shall be
treated as Syntera Shares for all
purposes hereunder. As used herein, "Subject Shares" shall refer exclusively to
the Syntera Shares, unless the Merger occurs on or before December 31, 1999, in
which event "Subject Shares" shall, after the Merger, refer exclusively to the
FemPartners Shares. As used herein, "Gross Exchange Value" shall mean the amount
of $341,250, and such amount shall not be (a) adjusted in the event of any stock
dividends, stock splits, reverse stock splits or recapitalizations to which the
Subject Shares are subject after the date of this Agreement or (b) affected by
any forfeiture or loss of FemPartners Shares withheld at the closing of the
Merger to be conditionally distributed to Shareholder pursuant the terms of the
Merger.
3. CONDITIONS TO EXCHANGE RIGHT. In addition to the other
terms and conditions contained in this Agreement, Shareholder shall only be
entitled to exchange the Subject Shares if each of the following conditions has
been satisfied:
(a) There shall not have been, on or before May 19, 2001 (the
"Determination Date"), any registered public offering of shares of the same
class as the Subject Shares, or any other transaction or event pursuant to which
shares of the same class as the Subject Shares shall have become publicly traded
at a per share price (existing immediately after such public offering or other
transaction or event) which would yield an amount equal to or greater than the
Gross Exchange Value upon a sale of all of the Subject Shares at such price; and
(b) Shareholder shall not be, or have been, at any time on or
prior to the date of the closing of any exchange of stock pursuant to this
Agreement (the "Closing Date"), in breach of, or default under, this Agreement,
any of the Acquisition Documents or any other
contract or agreement to which Shareholder and Syntera, FemPartners, APS and/
or any of their affiliates are parties; and
(c) At the Closing Date, Shareholder has all requisite legal
capacity and authority to engage in the transactions contemplated by this
Agreement, is the owner of all the Subject Shares, and the Subject Shares are
free of any and all liens, claims or encumbrances of any kind whatsoever; and
(d) If the Merger has not occurred on or prior to December 31,
1999, then on or before the Closing Date, Syntera shall not be, or have been, a
party to any merger, consolidation or similar transaction, or agreement with
respect thereto, pursuant to which Syntera was not or would not be, the named
surviving entity after such merger, consolidation or other transaction.
4. EXCHANGE NOTICE. In the event all of the conditions described in
Section 1 are satisfied as of the Determination Date and Shareholder elects to
exercise its right to exchange its Exchangeable Subject Shares (as hereinafter
defined), Shareholder shall provide written notice thereof (the "Exchange
Notice") to APS, which Exchange Notice must be received by APS not later than
the date (the "Expiration Date") which is one hundred eighty (180) calendar days
after the Determination Date. In the event (i) any of the conditions required
for an exchange to be permissible, as described in Section 1 above, fail to be
satisfied on or prior to the Determination Date, or (ii) any of the conditions
specified in subsections (b), (c) and (d) of Section 1 fail to be satisfied on
or prior to the Closing Date, or (iii) APS fails to receive an Exchange Notice
from Shareholder on or prior to the Expiration Date; then, in any such case, all
of Shareholder's rights under this Agreement shall automatically terminate and
be of no further force or effect whatsoever.
5. SHARE EXCHANGE.
(a) Shareholder's right to exchange its Subject Shares hereunder shall
apply as to all, but not less than all, of the Subject Shares which are eligible
for exchange as described in this subparagraph (a). Assuming Shareholder has
complied with all of the conditions allowing for an exchange pursuant to this
Agreement, all of the Subject Shares are eligible for exchange.
(b) In the event Shareholder has complied with all of the conditions
allowing for an exchange pursuant to this Agreement, the closing of any such
exchange (the "Closing") shall occur at the offices of APS in Austin, Texas, on
such day and at such time as the parties hereto may mutually agree upon, or in
the failure to so agree, at 10:00 a.m. Austin, Texas time on the first business
day that falls thirty (30) days after the later of (x) the Expiration Date, (y)
if a Lock-Up Period (as hereinafter defined) is imposed pursuant to Section 6
hereof, the day on which such Lock-Up Period ends, or (z) if a Market Delay (as
hereinafter defined) is imposed pursuant to Section 5(c) hereof, the day on
which such Market Delay ends. The maximum number of Subject Shares which
Shareholder has the right to exchange pursuant to subparagraph (a) of this
Section are hereinafter referred to as the "Exchangeable Subject Shares." At the
Closing, Shareholder shall be entitled to receive either:
(i) such shares of APS Common as is determined by dividing the
Gross Exchange Value by the average of the "bid" and "ask" prices for APS Common
as quoted by the National Association of Securities Dealers Automated Quotation
System at the close of trading on each of the last five (5) business days
immediately preceding the Closing Date; or
(ii) such shares of Prime Stock as is determined by dividing
the Gross Exchange Value by the average of the "bid" and "ask" prices for the
Prime Stock as quoted by the National Association of Securities Dealers
Automated Quotation System at the close of trading on each of the last five (5)
business days immediately preceding the Closing Date; or
(iii) cash or immediately available funds in the amount of
the Gross Exchange Value; or
(iv) any combination thereof (as determined by APS in its sole
discretion), equal in aggregate value to the Gross Exchange Value.
(c) In the event APS elects to satisfy its obligations under this
Section 5 in whole or in part with the issuance to Shareholder of shares of APS
Common or Prime common stock, APS shall have the right to delay the issuance of
such shares of APS Common or Prime common stock for up to ninety (90) calendar
days (the "Market Delay"), if, in APS' sole discretion, an issuance of shares of
APS Common or Prime common stock pursuant to this Agreement, or in combination
with any similar agreement or agreements, would depreciate the market value of
the APS Common or Prime common stock, as applicable.
(d) At the Closing, Shareholder shall tender its share certificate(s)
for all of the Exchangeable Subject Shares, duly endorsed in blank, to APS, and
shall also provide APS with an executed blank stock power, in form and substance
reasonably acceptable to APS, wherein Shareholder represents and warrants to APS
(i) that Shareholder has all necessary legal capacity, power and authority to
engage in the transactions contemplated hereby, and (ii) that Shareholder owns
all interests in and to the Exchangeable Subject Shares and that the
Exchangeable Subject Shares are being transferred to APS free and clear of all
liens, claims or encumbrances of any kind whatsoever.
(e) Any shares of APS Common or Prime Stock that Shareholder receives
in the exchange are hereinafter referred to as the "New Shares." The parties
acknowledge and agree that Shareholder shall receive a whole number of shares of
New Shares only, and that any fractional share amounts resulting from the
foregoing exchange calculation shall be rounded up or down, as the case may be,
to the next whole number of shares. At the Closing, Shareholder shall either
receive a share certificate or certificates for all its New Shares or, if APS is
unable to produce (or caused to be produced) such certificate or certificates by
the Closing Date, will receive a copy of a registered letter sent from APS to
the transfer agent instructing the transfer agent to deliver such certificate or
certificates in the name of Shareholder directly to Shareholder or Shareholder's
designee.
6. NEW SHARES TRANSFERABILITY. APS will have registered any shares of
APS Common exchanged hereunder with the Securities and Exchange Commission (the
"Commission"), and made such other filings and taken such other steps as
necessary, so that Shareholder may immediately sell, or otherwise convey, such
shares of APS Common without restriction (except as otherwise provided below).
Shareholder agrees to cooperate fully and in all respects with APS in connection
with any such registration, whether such cooperation is requested before or
after the Determination Date. Failure of Shareholder to cooperate fully,
including without limitation, promptly providing complete and accurate
information to APS, in connection with the registration of any APS Common
shares, whether such cooperation and/or information is requested before or after
the Determination Date or before or after Shareholder delivers any Exchange
Notice, shall automatically terminate Shareholder's rights under this Agreement.
Notwithstanding anything contained herein to the contrary, in the event that APS
is in the process, either at the Closing Date or at the Determination Date, of
registering and/or selling any of its capital stock in or pursuant to any
underwritten public offering, upon the written request of the lead underwriter
involved therein, Shareholder agrees, and shall then agree in writing in form
and substance reasonably acceptable to APS, to not sell, attempt to sell, or
solicit or accept any offers to sell or otherwise convey, any of its shares of
APS Common for such period of time (not to exceed one hundred eighty (180) days)
as may be requested by such lead underwriter (the "Lock-Up Period"). Any Prime
Stock exchanged hereunder will be registered with the Commission and will be
free of any and all liens, encumbrances and security interests, so that
Shareholder may immediately sell or otherwise convey such Prime Stock without
restriction.
7. MISCELLANEOUS.
(a) FEES AND EXPENSES. Each party hereto agrees to bear all
fees and expenses (including without limitation all fees and expenses for its
legal counsel and any accountants or other professional advisors) incurred in
connection with the transactions contemplated hereby.
(b) GOVERNING LAW AND VENUE. This Agreement shall be governed
by, and construed and enforced in accordance with, the laws of the State of
Texas (except the laws of Texas that would render such choice of law
ineffective). Venue for any action relating to this Agreement shall be proper
only in Travis County, Texas.
(c) COUNTERPARTS. This Agreement may be executed
simultaneously in one or more counterparts, each of which shall be deemed an
original, and all of which together shall constitute one and the same
instrument.
(d) INUREMENT. This Agreement shall be binding upon the
parties hereto and their respective heirs, legal representatives, successors and
permitted assigns. No party hereto may assign this Agreement, or any of their
rights or obligations hereunder, without the express prior written consent of
all parties hereto in each instance.
(e) NOTICES. Any notices required or permitted to be given
under this Agreement shall be given in writing and shall be deemed received (a)
when personally delivered to the relevant party at its address as set forth
below or (b) if sent by mail, on the third day
following the date when deposited in the United States mail, certified or
registered mail, postage pre-paid to the relevant party at its address indicated
below:
APS: American Physicians Service Group, Inc.
1301 Capital of Texas Highway, Suite C-300
Austin, Texas 78746-6550
Attn: President
Shareholder: Jonathan B. Buten, M.D.
5801 Round Table Cove
Austin, Texas 78746
Any party may change its address for purposes of this Agreement by proper notice
to the other party.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement,
intending to be legally bound hereby, as of the date first above written.
APS: AMERICAN PHYSICIANS SERVICE GROUP, INC.
By: /s/ W.H. Hayes
-----------------------------
Printed Name: W.H. Hayes
-----------------------------
Title: Sr. VP - Finance
-----------------------------
SHAREHOLDER:
/s/ Jonathan B. Buten, M.D.
-----------------------------